NADPH (Reduced NAD Phosphate) · Evidence-First Lite Reference

NADPH (Reduced NAD Phosphate) Lite reference · evidence-first overview + FAQ. Educational only.

Overview

This is a Lite reference page for NADPH (Reduced NAD Phosphate). For deep evidence (mechanism, dose-response, full PMID citations), please consult primary literature and the cross-linked references on related goal/lifestyle pages.

Tags

Body Systems: Mitochondrial & Cellular Energy · METABOLISM

Mechanisms: Anabolic reductive biosynthesis cofactor · Glutathione recycling

Evidence Tier: lite-tier-c-observation-30d

Layer: B (Lite reference)

Frequently Asked Questions

The questions below cover the most common questions on NADPH (Reduced NAD Phosphate). This is an evidence-first Lite reference page; for deep mechanism narratives, dose-response analyses, and full PMID citations please consult primary literature. Answers below intentionally disclose evidence-base limitations rather than overstate the supplement category.

1. What is NADPH?

NADPH is the reduced phosphate form of NADP+. It is central to reductive biosynthesis, glutathione recycling, and redox enzyme systems, but that endogenous cofactor biology is not the same thing as evidence for oral NADPH supplementation.

2. Are there human clinical trials of NADPH supplements?

No human clinical trial currently published · educational reference only · supplement market dosing unsupported by human evidence. This is the central disclosure for the NADPH Lite page and the reason the public card keeps NADPH in Tier C observation-30d framing.

3. Can NADPH be treated like NADH or NMN?

No. NADH, NMN, and NR have human evidence anchors in the NAD+ precursor family. NADPH has important endogenous biology, but the current evidence review found no human RCT evidence supporting NADPH-specific supplement dosing or efficacy claims.

4. What dose frame is used here?

There is no established human dose. The public card notes that 10-30 mg/day appears in the supplement market, but explicitly marks that range as unsupported by human RCT evidence rather than a recommended intake.

5. Where does this page sit in the evidence library?

This is a Lite reference page. For deeper evidence please consult primary literature on endogenous NADPH redox biology, glutathione recycling, and the absence of human supplementation trials before inferring antioxidant, longevity, or performance benefits.

← All Ingredients

Ask Agent Axor